Doctor Adhiala Zyggo Barano
Badau Bergerak Hospital, Kapuas Hulu (Indonesia)
Safety profile of novel angiotensin II type-1 receptor neprilysin inhibitor lcz696 (sacubitril/valsartan) - a collaborative summary from clinical trials
Event: Heart Failure 2018
Topic: Pharmacotherapy
Session: Chronic Heart Failure – Treatment
ESC 365 is supported by
